BridgeMD
New treatment option for Opioid Craving
Official title Developing a Clinical Outcome Assessment for Opioid Craving
ClinicalTrials.gov ID: NCT05109429
What this study is testing
- What it's testing
- The purpose of this study is to collect information about opioid craving so that the investigators can develop an opioid craving assessment to improve treatments for individuals with opioid use disorder. To collect this information, the investigators are recruiting individuals in treatment for opioid use disorder who will complete cue-induced opioid craving tasks where these individuals will: (1) look at pictures of neutral objects and touch neutral objects (e.g., water bottles or flashlights), (2) look at opioid-related images, and (3) look and touch opioid-related objects.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- 18 years of age and older
- Opioid-positive urine sample at admission visit (excluding individuals receiving Naltrexone).
- Current opioid use disorder per Diagnostic Statistical Manual (DSM)-5
- Currently in treatment for opioid use disorder
You likely can't join if
- Being pregnant or breastfeeding, or may become pregnant during the trial
- History of psychosis or mania or other serious psychiatric disorders assessed by the Mini International Neuropsychiatric Interview
- Past 30-day suicidal behavior assessed by the Columbia Suicide Severity Rating Scale
- Have circumstances that would interfere with study participation (e.g., impending jail).
- Positive for illicit substances except opioids and cannabis
- Current substance use disorder other than opioid or nicotine
See the full eligibility criteria
- 18 years of age and older
- Opioid-positive urine sample at admission visit (excluding individuals receiving Naltrexone).
- Current opioid use disorder per Diagnostic Statistical Manual (DSM)-5
- Currently in treatment for opioid use disorder
- Being pregnant or breastfeeding, or may become pregnant during the trial
- History of psychosis or mania or other serious psychiatric disorders assessed by the Mini International Neuropsychiatric Interview
- Past 30-day suicidal behavior assessed by the Columbia Suicide Severity Rating Scale
- Have circumstances that would interfere with study participation (e.g., impending jail).
- Positive for illicit substances except opioids and cannabis
- Current substance use disorder other than opioid or nicotine
- Current intoxication
The study team makes the final eligibility decision.
Where it's taking place
- Baltimore, Maryland, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baltimore, Maryland, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.